Cargando…
Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
BACKGROUND: High incidence of cardiovascular events has been described among patients with COVID-19 and since the beginning of the pandemic concerns have been expressed with medical treatments for cardiovascular disease, as they could contribute to the severity of illness in patients with COVID-19....
Autores principales: | Esteban-Lucia, L, Zambrano Chacon, M A, Venegas Rodriguez, A M, Devesa-Arbiol, A, Gonzalez-Rodriguez, M, Maure-Blesa, L, Avila-Barahona, P, Pello-Lazaro, A M, Gonzalez-Lorenzo, O, Kallmeyer-Mayor, A M, Fernandez-Roblas, R, Villar-Alvarez, F, Tunon, J, Acena Navarro, A, Franco-Pelaez, J A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767614/ http://dx.doi.org/10.1093/eurheartj/ehab724.3006 |
Ejemplares similares
-
Statin use is associated with reduced mortality after respiratory viral infection
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2021) -
Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021) -
Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017) -
The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study
por: Venegas‐Rodríguez, Ana, et al.
Publicado: (2023) -
Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)